A single mega dose of rFVIIa for treatment of hemophilia patients with inhibitors.

被引：0
|
作者：
Kenet, G [1 ]
Lubetsky, A [1 ]
Luboshitz, J [1 ]
Varon, D [1 ]
Martinowitz, U [1 ]
机构：
[1] Chaim Sheba Med Ctr, Natl Hemophilia Ctr, Tel Hashomer, Israel
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1147
引用
收藏
页码：267A / 267A
页数：1
相关论文
共 50 条
  • [1] Randomized, prospective clinical trial of rFVIIa for secondary prophylaxis in hemophilia patients with inhibitors.
    Konkle, Barbara A.
    Ebbesen, Liselotte S.
    Friedrich, Ute
    Bianco, Raul P.
    Lissitchkov, Toshko
    Rusen, Luminita
    Serban, Margit A.
    BLOOD, 2006, 108 (11) : 230A - 230A
  • [2] RFVIIA PROPHYLAXIS IN HEMOPHILIA PATIENTS WITH INHIBITORS
    Torres, O. W.
    Scoles, G.
    Paoloski, G.
    Pollola, J.
    Ferro, A. M.
    Buceta, A.
    Cermelj, M.
    VOX SANGUINIS, 2010, 99 : 502 - 502
  • [3] Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors
    Knight, Chris
    Dano, Anne Moller
    Kennedy-Martin, Tessa
    ADVANCES IN THERAPY, 2009, 26 (01) : 68 - 88
  • [4] Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors
    Chris Knight
    Anne Møller Danø
    Tessa Kennedy-Martin
    Advances in Therapy, 2009, 26 : 68 - 88
  • [5] Home treatment with recombinant factor VIIa (rFVIIa) in hemophilia A or B patients with inhibitors
    Laurian, Y
    Goudemand, J
    Négrier, C
    Vicariot, M
    Marqués-Verdier, A
    Fonlupt, J
    Gaillard, S
    Fressinaud, E
    Dirat, G
    Sultan, Y
    Faradji, A
    Clayessens, S
    Guérois, C
    Peynet, J
    Bertrand, MA
    Digy, JP
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 15 - 15
  • [6] Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry
    Parameswaran, R
    Shapiro, AD
    Gill, JC
    Kessler, CM
    HAEMOPHILIA, 2005, 11 (02) : 100 - 106
  • [7] Comparison of two doses of recombinant VIIA (rFVIIA) for producing hemostasis during and after surgery in patients with hemophilia A or B and inhibitors and patients with acquired inhibitors.
    Cooper, HA
    Gilchrist, GS
    Hoots, WK
    Shapiro, A
    BLOOD, 1997, 90 (10) : 2665 - 2665
  • [8] The impact of rebleeds in cost modelling of treatment strategies in patients with hemophilia A and inhibitors.
    Huth-Kuehne, Angela
    Lages, Peter
    Zimmermann, Rainer
    BLOOD, 2006, 108 (11) : 90B - 90B
  • [9] A cost minimization model for the treatment of patients with hemophilia A and high titer inhibitors.
    Bohn, RL
    Putnam, KG
    Ewenstein, BM
    Winkelmayer, WC
    Avorn, J
    BLOOD, 2002, 100 (11) : 222A - 222A
  • [10] APCC versus RFVIIA in treatment of hemophilia patients with inhibitors: a structured review of the pharmacoeconomic literature
    Hay, J. W.
    Zhou, Z.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 834 - 834
12345